APA (7th ed.) Citation

S, P., M, H., KC, A., LP, R., M, R., T, L., . . . MV, N. (2026). SUNRAY-01 trial protocol: An innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC. Future oncology (London, England), 22(9), 1073. https://doi.org/10.1080/14796694.2026.2651961

Chicago Style (17th ed.) Citation

S, Peters, et al. "SUNRAY-01 Trial Protocol: An Innovative Study Design of Olomorasib and Pembrolizumab with or Without Chemotherapy in KRAS G12C NSCLC." Future Oncology (London, England) 22, no. 9 (2026): 1073. https://doi.org/10.1080/14796694.2026.2651961.

MLA (9th ed.) Citation

S, Peters, et al. "SUNRAY-01 Trial Protocol: An Innovative Study Design of Olomorasib and Pembrolizumab with or Without Chemotherapy in KRAS G12C NSCLC." Future Oncology (London, England), vol. 22, no. 9, 2026, p. 1073, https://doi.org/10.1080/14796694.2026.2651961.